{{Rsnum
|rsid=6691117
|Gene=CR1
|Chromosome=1
|position=207609586
|Orientation=plus
|GMAF=0.3893
|Gene_s=CR1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|StabilizedOrientation=plus
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 68.8 | 26.8 | 4.5
| HCB | 65.0 | 29.9 | 5.1
| JPT | 62.2 | 34.2 | 3.6
| YRI | 2.1 | 15.1 | 82.9
| ASW | 5.3 | 42.1 | 52.6
| CHB | 65.0 | 29.9 | 5.1
| CHD | 51.9 | 40.7 | 7.4
| GIH | 30.7 | 38.6 | 30.7
| LWK | 2.8 | 27.5 | 69.7
| MEX | 48.3 | 43.1 | 8.6
| MKK | 14.1 | 48.7 | 37.2
| TSI | 63.0 | 32.0 | 5.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=23591632
|Title=Maternal coding variants in complement receptor 1 and spontaneous idiopathic preterm birth
|OA=1
}}

{{PMID Auto
|PMID=24018213
|Title=Missense variants in CR1 are associated with increased risk of Alzheimer' disease in Han Chinese
}}

{{PMID Auto
|PMID=21700265
|Title=Complement receptor 1 gene variants are associated with erythrocyte sedimentation rate.
|OA=1
}}

{{PMID Auto
|PMID=23856853
|Title=Association of a complement receptor 1 gene variant with baseline erythrocyte sedimentation rate levels in patients starting anti-TNF therapy in a UK rheumatoid arthritis cohort: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}